Literature DB >> 20477273

Constrictive bronchiolitis obliterans: the fibrotic airway disorder.

Gary R Epler1.   

Abstract

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar submucosal layer with continual external circular scarring. The fibrotic and destructive nature of this lesion is the defining characteristic. Although patchy, the airway may become slit-like or obliterated from this fibrotic process, resulting in bronchiolitis obliterans. Constrictive bronchiolitis is limited to the bronchioles and does not extend into the alveoli. The clinical features of constrictive bronchiolitis consist of a chest radiograph that is often normal, early inspiratory crackles and irreversible airflow obstruction by pulmonary function testing. Chest CT scans show a mosaic pattern, air trapping by the expiratory film, bronchiolectasis and thickened small airway walls. Although idiopathic constrictive bronchiolitis is rare, the lesion is common among lung-transplant recipients. The lesion also occurs from certain types of toxic fumes, some of the connective tissue diseases, specific types of medications and post respiratory infection. Unusual exposures have also been described as a cause of constrictive bronchiolitis, such as consumption of the leafy vegetable Sauropus androgynus in far eastern Asia and from inhaling diacetyl, the ketone butter flavoring used in microwave popcorn production. Empirical treatment consists of corticosteroid and immunosuppressive agents. Antifibrotic agents may be successful in the future. This is generally a nonsteroid-responsive lesion and for disabling disease, lung transplantation can be a successful option.

Entities:  

Year:  2007        PMID: 20477273     DOI: 10.1586/17476348.1.1.139

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  7 in total

Review 1.  Non-malignant respiratory disease among workers in industries using styrene-A review of the evidence.

Authors:  Randall J Nett; Jean M Cox-Ganser; Ann F Hubbs; Avima M Ruder; Kristin J Cummings; Yuh-Chin T Huang; Kathleen Kreiss
Journal:  Am J Ind Med       Date:  2017-02       Impact factor: 2.214

2.  Loss of basal cells precedes bronchiolitis obliterans-like pathological changes in a murine model of chlorine gas inhalation.

Authors:  Emily G O'Koren; Brigid L M Hogan; Michael Dee Gunn
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

3.  Diagnosis and treatment of constrictive bronchiolitis.

Authors:  Gary R Epler
Journal:  F1000 Med Rep       Date:  2010-04-27

4.  Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction.

Authors:  L A Borthwick; M I Suwara; S C Carnell; N J Green; R Mahida; D Dixon; C S Gillespie; T N Cartwright; J Horabin; A Walker; E Olin; M Rangar; A Gardner; J Mann; P A Corris; D A Mann; A J Fisher
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

5.  Respiratory Health after Military Service in Southwest Asia and Afghanistan. An Official American Thoracic Society Workshop Report.

Authors:  Eric Garshick; Joseph H Abraham; Coleen P Baird; Paul Ciminera; Gregory P Downey; Michael J Falvo; Jaime E Hart; David A Jackson; Michael Jerrett; Ware Kuschner; Drew A Helmer; Kirk D Jones; Silpa D Krefft; Timothy Mallon; Robert F Miller; Michael J Morris; Susan P Proctor; Carrie A Redlich; Cecile S Rose; Rudolph P Rull; Johannes Saers; Aaron I Schneiderman; Nicholas L Smith; Panayiotis Yiallouros; Paul D Blanc
Journal:  Ann Am Thorac Soc       Date:  2019-08

6.  The clinico-radiological profile of obliterative bronchiolitis in a tertiary care center.

Authors:  H S Suhas; Ketaki Utpat; Unnati Desai; Jyotsna M Joshi
Journal:  Lung India       Date:  2019 Jul-Aug

7.  A follow-up study of post infectious obliterative bronchiolitis in adults and comparative analysis with chronic obstructive pulmonary disease.

Authors:  Dipti Gothi; Shweta Anand; Mahismita Patro; Sameer Vaidya; Ishani Deshmukh
Journal:  Lung India       Date:  2021 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.